DARE
Dare Bioscience IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$32.61M
P/E Ratio
—
EPS
$-1.20
Beta
0.90
52W High
$3.43
52W Low
$1.27
50-Day MA
$1.75
200-Day MA
$1.99
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.27
PEG Ratio
0.00
About Dare Bioscience Inc
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $1.03M |
| Gross Profit (TTM) | 734,390 |
| EBITDA | $-11.92M |
| Operating Margin | -143.70% |
| Return on Equity | -2543.00% |
| Return on Assets | -31.00% |
| Revenue/Share (TTM) | $0.09 |
| Book Value | $0.20 |
| Price-to-Book | 10.81 |
| Price-to-Sales (TTM) | 31.66 |
| EV/Revenue | 8.41 |
| EV/EBITDA | -2.06 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -94.60% |
| Shares Outstanding | $14.56M |
| Float | $13.31M |
| % Insiders | 8.57% |
| % Institutions | 8.44% |
Historical Volatility
HV 10-Day
65.36%
HV 20-Day
86.78%
HV 30-Day
73.05%
HV 60-Day
58.09%
HV Rank
73.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($9.67 target)
1
Strong Buy2
BuyData last updated: 4/28/2026